Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Devilee

Showing results (101-110 of 282) with videos related to

Pageof 29
Sort By:
Plos Genetics|February 9, 2010
Mutations in SLC29A3, encoding an equilibrative nucleoside transporter ENT3, cause a familial histiocytosis syndrome (Faisalabad histiocytosis) and familial Rosai-Dorfman diseaseNeil V Morgan, Mark R Morris, Hakan Cangul, et al.
Oncotarget|January 19, 2017
Loss of maternal chromosome 11 is a signature event in SDHAF2, SDHD, and VHL-related paragangliomas, but less significant in SDHB-related paragangliomasAttje S Hoekstra, Erik F Hensen, Ekaterina S Jordanova, et al.
Breast Care (Basel, Switzerland)|June 15, 2022
Risk-Adjusted Cancer Screening and Prevention (RiskAP): Complementing Screening for Early Disease Detection by a Learning Screening Based on Risk FactorsRita K Schmutzler, Björn Schmitz-Luhn, Bettina Borisch, et al.
Breast Cancer Research and Treatment|July 15, 2019
Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriersBernadette A M Heemskerk-Gerritsen, Agnes Jager, Linetta B Koppert, et al.
European Journal of Human Genetics : EJHG|May 9, 2013
CHEK2*1100delC homozygosity in the Netherlands--prevalence and risk of breast and lung cancerPetra E A Huijts, Antoinette Hollestelle, Brunilda Balliu, et al.
Journal of Medical Genetics|September 22, 2022
Clinical applicability of the Polygenic Risk Score for breast cancer risk prediction in familial casesInge M M Lakeman, Mar D M Rodríguez-Girondo, Andrew Lee, et al.
Journal of Medical Genetics|October 12, 2012
Rare variants in XRCC2 as breast cancer susceptibility allelesFlorentine S Hilbers, Juul T Wijnen, Nicoline Hoogerbrugge, et al.
Cancer Research|February 12, 2004
Are ATM mutations 7271T-->G and IVS10-6T-->G really high-risk breast cancer-susceptibility alleles?Csilla I Szabo, Mieke Schutte, Annegien Broeks, et al.
Breast Cancer Research and Treatment|December 5, 2009
Subtypes of familial breast tumours revealed by expression and copy number profilingNic Waddell, Jeremy Arnold, Sibylle Cocciardi, et al.
Journal of Medical Genetics|November 29, 2013
Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutationsRichard M Brohet, Maria E Velthuizen, Frans B L Hogervorst, et al.
Pageof 29

Showing results (101-110 of 282) with videos related to

Sort By:
Pageof 29
Plos Genetics|February 9, 2010
Mutations in SLC29A3, encoding an equilibrative nucleoside transporter ENT3, cause a familial histiocytosis syndrome (Faisalabad histiocytosis) and familial Rosai-Dorfman diseaseNeil V Morgan, Mark R Morris, Hakan Cangul, et al.
Oncotarget|January 19, 2017
Loss of maternal chromosome 11 is a signature event in SDHAF2, SDHD, and VHL-related paragangliomas, but less significant in SDHB-related paragangliomasAttje S Hoekstra, Erik F Hensen, Ekaterina S Jordanova, et al.
Breast Care (Basel, Switzerland)|June 15, 2022
Risk-Adjusted Cancer Screening and Prevention (RiskAP): Complementing Screening for Early Disease Detection by a Learning Screening Based on Risk FactorsRita K Schmutzler, Björn Schmitz-Luhn, Bettina Borisch, et al.
Breast Cancer Research and Treatment|July 15, 2019
Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriersBernadette A M Heemskerk-Gerritsen, Agnes Jager, Linetta B Koppert, et al.
European Journal of Human Genetics : EJHG|May 9, 2013
CHEK2*1100delC homozygosity in the Netherlands--prevalence and risk of breast and lung cancerPetra E A Huijts, Antoinette Hollestelle, Brunilda Balliu, et al.
Journal of Medical Genetics|September 22, 2022
Clinical applicability of the Polygenic Risk Score for breast cancer risk prediction in familial casesInge M M Lakeman, Mar D M Rodríguez-Girondo, Andrew Lee, et al.
Journal of Medical Genetics|October 12, 2012
Rare variants in XRCC2 as breast cancer susceptibility allelesFlorentine S Hilbers, Juul T Wijnen, Nicoline Hoogerbrugge, et al.
Cancer Research|February 12, 2004
Are ATM mutations 7271T-->G and IVS10-6T-->G really high-risk breast cancer-susceptibility alleles?Csilla I Szabo, Mieke Schutte, Annegien Broeks, et al.
Breast Cancer Research and Treatment|December 5, 2009
Subtypes of familial breast tumours revealed by expression and copy number profilingNic Waddell, Jeremy Arnold, Sibylle Cocciardi, et al.
Journal of Medical Genetics|November 29, 2013
Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutationsRichard M Brohet, Maria E Velthuizen, Frans B L Hogervorst, et al.
Pageof 29